Professor Xavier Griffin spearheads academic orthopaedics at QMUL and Barts Health, having joined in August 2020 as the inaugural chair of Bone & Joint Health. Xavier’s vision is for worldclass excellence in research and clinical academic training; providing opportunity for the next generation of clinician scientists to realise their aspirations.
Xavier is a NIHR Clinician Scientist and has been awarded over £10m of research funding. He has over 80 peer reviewed publications including in the New England Journal of Medicine, He is a recognised research leader in the management of hip fracture and is excited to have just launched the WHiTE PLATFORM study with colleagues at University of Oxford. Xavier is Chief Investigator for a number of National Institute Health Research funded clinical trials, having led 8 in the last 5 years and supported a further 5.
Xavier is driven by having meaningful impact on patient care; his research is focused on the clinical and cost effectiveness of new and existing treatments to improve bone and joint health and has been cited by the National Institute of Clinical Excellence.
Having realised that boxing may not be the best sport to combine with a surgical career, outside of work Xavier can be found mountain biking or rock climbing usually with his young son in tow!
Adhesive Capsulitis Corticosteroid and Dilation Randomised Controlled Trial: A Feasibility Study in Primary Care
Adhesive Capsulitis Corticosteroid and Dilation Randomised Controlled Trial: A Feasibility Study in Primary CareBackgroundShoulder pain accounts for 3% of all visits to a GP, with frozen shoulder being the most common cause of pain. Prevalence of frozen shoulder is...
DUALITY: Dual mobility (DM) versus standard articulation total hip replacement (THR) in the treatment of older adults with a hip fracture
DUALITY: Dual mobility (DM) versus standard articulation total hip replacement (THR) in the treatment of older adults with a hip fractureBackgroundWorldwide there are 1.3 million hip fractures with more than 70,000 hip fractures in the UK every year. The global cost...
The management of hip fracture in older adults Background Hip fracture is one of the biggest challenges facing patients and healthcare systems. Worldwide there are 1.3 million hip fractures with more than 70,000 hip fractures in the UK every year. These figures are...
Priority Setting Partnership in Major TraumaWhat is the Major Trauma Priority Setting Partnership?This James Lind Alliance (JLA) Priority Setting Partnership (PSP) brings together all involved and affected by major trauma to prioritise the top 10 research...
Improving ethnic representation within the Tendon Human Cell Atlas Background TO BE ADDED. Summary Barts Health NHS Trust is the largest NHS hospital group or Trust in the UK, comprising six hospitals. The hospitals serve the ethnically diverse communities of over 2.6...
Mapping Barts Health NHS Trust electronic health record to the OMOP data modelBackgroundThe European Health Data and Evidence Network (EHDEN), an IMI 2 consortium with 23 partners, is a multi-stakeholder, interdisciplinary, open-science collaborative maximising the...
Effect on health-related quality of life of the X-Bolt dynamic plating system versus the sliding hip screw for the fixation of trochanteric fractures of the hip in adults: the WHiTE Four randomized clinical trial
Griffin XL, Achten J, O’Connor HM, Cook JA, Costa ML.
Recovery of health-related quality of life in a United Kingdom hip fracture population. The Warwick Hip Trauma Evaluation-a prospective cohort study.
Griffin XL., Parsons N., Achten J., Fernandez M., Costa ML.
Cemented or Uncemented Hemiarthroplasty for Intracapsular Hip Fracture
Miguel A. Fernandez, Ph.D., Juul Achten, Ph.D., Nicholas Parsons, Ph.D., Xavier L. Griffin, Ph.D., May-Ee Png, Ph.D., Jenny Gould, Alwin McGibbon, B.A., and Matthew L. Costa, Ph.D.
Enhanced rehabilitation and care models for adults with dementia following hip fracture surgery.
Smith TO., Gilbert AW., Sreekanta A., Sahota O., Griffin XL., Cross JL., Fox C., Lamb SE.
If you would like to find out more about opportunities to drive our research, please email us.